Recent News

• 04.14.2025 - Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
• 04.14.2025 - Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
• 04.14.2025 - Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
• 03.31.2025 - Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
• 03.31.2025 - Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
• 03.31.2025 - Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
• 03.19.2025 - Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
• 03.19.2025 - Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
• 03.19.2025 - Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

Recent Filings

• 04.15.2025 - EX-99.1 EX-99.1
• 04.15.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.15.2025 - 8-K Current report
• 03.31.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities